Accelerating Medicines Partnership in Type 2 Diabetes and Common Metabolic Diseases: Collaborating to Maximize the Value of Genetic and Genomic Data.
Saved in:
| Title: | Accelerating Medicines Partnership in Type 2 Diabetes and Common Metabolic Diseases: Collaborating to Maximize the Value of Genetic and Genomic Data. |
|---|---|
| Authors: | Costanzo MC; Programs in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA., Akolkar B; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Claussnitzer M; Broad Diabetes Initiative and Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, Broad Institute of MIT and Harvard, Cambridge, MA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA.; Endocrine Division, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Harvard University, Boston, MA., Florez JC; Programs in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Harvard University, Boston, MA.; Department of Medicine, Mass General Brigham, Boston, MA., Gloyn AL; Department of Pediatrics, Department of Genetics, and Stanford Diabetes Research Center, Stanford School of Medicine, Stanford University, Palo Alto, CA., Grant SFA; Center for Spatial and Functional Genomics, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Divisions of Human Genetics and Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA., Kaestner KH; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Manning AK; Programs in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Harvard University, Boston, MA.; Clinical and Translational Epidemiology Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA., Mohlke KL; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC., Parker SCJ; Gilbert S. Omenn Department of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, MI.; Department of Human Genetics, University of Michigan, Ann Arbor, MI.; Department of Biostatistics, University of Michigan, Ann Arbor, MI., Titchenell PM; Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Udler MS; Programs in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Harvard University, Boston, MA.; Department of Medicine, Mass General Brigham, Boston, MA., Jones MA; Foundation for the National Institutes of Health, North Bethesda, MD., Kamphaus TN; Foundation for the National Institutes of Health, North Bethesda, MD., Fischer RA; Foundation for the National Institutes of Health, North Bethesda, MD., McCarthy MI; Wellcome Centre for Human Genetics, University of Oxford, Oxford, U.K., Miller MR; Internal Medicine Research Unit, Pfizer Research and Development, Pfizer, Cambridge, MA., Boehnke M; Gilbert S. Omenn Department of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, MI., Flannick J; Programs in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA.; Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA.; Department of Pediatrics, Harvard Medical School, Boston, MA., Burtt NP; Programs in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA. |
| Corporate Authors: | AMP T2D Consortium, AMP CMD Consortium |
| Source: | Diabetes [Diabetes] 2025 Jul 01; Vol. 74 (7), pp. 1089-1098. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1939-327X |
|---|---|
| DOI: | 10.2337/db25-0042 |
